PH19275A - New xanthine compounds - Google Patents
New xanthine compoundsInfo
- Publication number
- PH19275A PH19275A PH29308A PH29308A PH19275A PH 19275 A PH19275 A PH 19275A PH 29308 A PH29308 A PH 29308A PH 29308 A PH29308 A PH 29308A PH 19275 A PH19275 A PH 19275A
- Authority
- PH
- Philippines
- Prior art keywords
- image
- alkyl
- hydrogen
- hydroxyl
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8213155A FR2531085A1 (fr) | 1982-07-28 | 1982-07-28 | Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH19275A true PH19275A (en) | 1986-02-21 |
Family
ID=9276395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH29308A PH19275A (en) | 1982-07-28 | 1983-07-27 | New xanthine compounds |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US4548820A (de) |
| EP (1) | EP0103497B1 (de) |
| JP (1) | JPS5942383A (de) |
| KR (1) | KR870001268B1 (de) |
| AT (1) | ATE17728T1 (de) |
| AU (1) | AU560809B2 (de) |
| CA (1) | CA1207766A (de) |
| DD (1) | DD216934A5 (de) |
| DE (1) | DE3362022D1 (de) |
| DK (1) | DK157550C (de) |
| ES (1) | ES524532A0 (de) |
| FR (1) | FR2531085A1 (de) |
| GR (1) | GR78891B (de) |
| HU (1) | HU188353B (de) |
| IE (1) | IE55773B1 (de) |
| IL (1) | IL69362A (de) |
| MA (1) | MA19860A1 (de) |
| NO (1) | NO159091C (de) |
| NZ (1) | NZ205035A (de) |
| OA (1) | OA07508A (de) |
| PH (1) | PH19275A (de) |
| PT (1) | PT77110B (de) |
| SU (2) | SU1240361A3 (de) |
| ZA (1) | ZA835496B (de) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH648559A5 (de) * | 1981-07-20 | 1985-03-29 | Siegfried Ag | Theophyllinderivate und verfahren zu deren herstellung. |
| FR2558162B1 (fr) * | 1984-01-17 | 1986-04-25 | Adir | Nouveaux derives de la xanthine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant |
| HU197746B (en) * | 1985-09-05 | 1989-05-29 | Sandoz Ag | Process for producing xantin derivatives and pharmaceutical compositions containing them |
| US4810706A (en) * | 1985-12-20 | 1989-03-07 | Recherche Syntex | Piperazine derivatives of theophylline and theobromine |
| GB8716313D0 (en) * | 1987-07-10 | 1987-08-19 | Janssen Pharmaceutica Nv | 2-(heterocyclylalkyl)imidazopyridines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| US5290782A (en) * | 1989-09-01 | 1994-03-01 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives |
| FR2659656B1 (fr) * | 1990-03-15 | 1994-09-09 | Sanofi Sa | Derives de pyrimidinedione-2,4 et medicaments les contenant. |
| DE4019892A1 (de) * | 1990-06-22 | 1992-01-02 | Boehringer Ingelheim Kg | Neue xanthinderivate |
| US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
| JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
| WO1994025462A1 (en) * | 1993-05-03 | 1994-11-10 | The United States Of America, Represented By The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| US5661153A (en) * | 1994-07-19 | 1997-08-26 | Japan Energy Corporation | 1-arylpyrimidine derivatives and pharmaceutical use thereof |
| DE19702785A1 (de) * | 1997-01-27 | 1998-07-30 | Bayer Ag | Neue cyclische Harnstoffderivate |
| DE60043318D1 (de) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistische kombination von pumafentrine und salmeterol |
| KR20050115331A (ko) | 2003-04-01 | 2005-12-07 | 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. | 불임증 포스포디에스터라제의 억제제 |
| WO2004096228A1 (en) | 2003-04-25 | 2004-11-11 | Novacardia, Inc. | Method of improved diuresis in individuals with impaired renal function |
| US20050239759A1 (en) * | 2004-04-16 | 2005-10-27 | Lauren Otsuki | Method of treatment of disease using an adenosine A1 receptor antagonist and an aldosterone inhibitor |
| JP2008517029A (ja) * | 2004-10-22 | 2008-05-22 | スミスクライン・ビーチャム・コーポレイション | Ｈｍ７４ａ受容体活性を有するキサンチン誘導体 |
| US20100029681A1 (en) * | 2006-05-26 | 2010-02-04 | Hassan Pajouhesh | Heterocyclic compounds as calcium channel blockers |
| JP2008025761A (ja) * | 2006-07-24 | 2008-02-07 | Kanaflex Corporation | 排水管更生用樹脂管 |
| RU2333212C3 (ru) * | 2007-03-29 | 2019-08-26 | Общество С Ограниченной Ответственностью "Фармвинг" | ПРОИЗВОДНЫЕ 1-И 7-[ω-(БЕНЗГИДРИЛ-4-ПИПЕРАЗИНИЛ-1)АЛКИЛ]-3-АЛКИЛКСАНТИНОВ, ОБЛАДАЮЩИЕ ПРОТИВОГИСТАМИННОЙ И АНТИАЛЛЕРГИЧЕСКОЙ АКТИВНОСТЬЮ |
| HUE031039T2 (en) | 2007-03-29 | 2017-06-28 | Joint-Stock Company Obninsk Chemical Pharmaceutical Company | An antihistamine and an anti-allergenic agent and a method for its preparation |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH409974A (de) * | 1959-03-25 | 1966-03-31 | Merckle Kg Chem Pharm L | Verfahren zur Herstellung neuer therapeutisch wirksamer Coffeino-(8)-alkylendiamine |
| GB1133989A (en) * | 1964-12-08 | 1968-11-20 | Chugai Pharmaceutical Co Ltd | Theophylline derivatives, their salts and process for preparing the same |
| FR7828M (de) * | 1967-11-13 | 1970-05-25 | ||
| JPS55118488A (en) * | 1979-03-05 | 1980-09-11 | Eisai Co Ltd | Theobromine derivative and its preparation |
| JPS5618983A (en) * | 1979-07-25 | 1981-02-23 | Eisai Co Ltd | Theophylline derivative and its preapration |
| US4426383A (en) * | 1980-09-04 | 1984-01-17 | Eisai Co., Ltd. | Theophylline and theobromine derivatives |
| DE3046927A1 (de) * | 1980-12-11 | 1982-07-15 | Josef Dipl.-Chem.Dr.rer.nat. 1000 Berlin Klosa | 8-dialkylaminoalkylaether-coffein-platin-komplexe , verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
| ES8303412A1 (es) * | 1981-10-06 | 1983-02-01 | Invest Tecnica Aplicada | Procedimiento de obtencion de nuevas xantinas con actividad farmacologica |
-
1982
- 1982-07-28 FR FR8213155A patent/FR2531085A1/fr active Granted
-
1983
- 1983-07-22 KR KR1019830003383A patent/KR870001268B1/ko not_active IP Right Cessation
- 1983-07-25 DE DE8383401518T patent/DE3362022D1/de not_active Expired
- 1983-07-25 EP EP83401518A patent/EP0103497B1/de not_active Expired
- 1983-07-25 AT AT83401518T patent/ATE17728T1/de not_active IP Right Cessation
- 1983-07-25 US US06/516,946 patent/US4548820A/en not_active Expired - Fee Related
- 1983-07-26 SU SU833621202A patent/SU1240361A3/ru active
- 1983-07-26 GR GR72044A patent/GR78891B/el unknown
- 1983-07-27 NO NO832742A patent/NO159091C/no unknown
- 1983-07-27 IE IE1762/83A patent/IE55773B1/en not_active IP Right Cessation
- 1983-07-27 HU HU832638A patent/HU188353B/hu not_active IP Right Cessation
- 1983-07-27 CA CA000433287A patent/CA1207766A/fr not_active Expired
- 1983-07-27 PT PT77110A patent/PT77110B/pt active IP Right Revival
- 1983-07-27 NZ NZ205035A patent/NZ205035A/en unknown
- 1983-07-27 DK DK342883A patent/DK157550C/da not_active IP Right Cessation
- 1983-07-27 IL IL69362A patent/IL69362A/xx not_active IP Right Cessation
- 1983-07-27 ZA ZA835496A patent/ZA835496B/xx unknown
- 1983-07-27 PH PH29308A patent/PH19275A/en unknown
- 1983-07-27 DD DD83253414A patent/DD216934A5/de not_active IP Right Cessation
- 1983-07-27 AU AU17361/83A patent/AU560809B2/en not_active Ceased
- 1983-07-28 JP JP58138664A patent/JPS5942383A/ja active Granted
- 1983-07-28 ES ES524532A patent/ES524532A0/es active Granted
- 1983-07-28 MA MA20081A patent/MA19860A1/fr unknown
- 1983-07-28 OA OA58075A patent/OA07508A/xx unknown
-
1984
- 1984-06-13 SU SU843749947A patent/SU1245261A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR78891B (de) | ||
| ES2002720A6 (es) | Procedimiento para preparar 2-hidroxi-3-fenoxipropilaminas | |
| DE3361100D1 (en) | Disubstituted polymethylene imines, processes for their preparation and pharmaceutical compositions containing them | |
| IL83141A (en) | Solutions of oxazophosphorins having improved stability and their preparation | |
| FI895921A0 (fi) | Enzymhaemmande aminosyraderivat, foerfarande foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning. | |
| ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
| PT77231B (en) | Process for the preparation of 2-nitro-1,1-ethenediamines having a hypotensive effect and their use for the preparation of pharmaceutical compositions with a hypotensive effect | |
| DK292883D0 (da) | Fremgangsmade til fremstilling af ketenthioacetaler eller salte deraf | |
| IL93989A0 (en) | Pharmaceutical compositions comprising heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases | |
| ATE62908T1 (de) | Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung. | |
| SE8100846L (sv) | Antirinovirusmedel | |
| ES527353A0 (es) | Procedimiento de preparacion de nuevos derivados de la nitrosourea | |
| ES8405790A1 (es) | Procedimiento de preparacion de nuevos derivados de piperazina y de homopiperazina. | |
| SE8603589L (sv) | Metylendioxifenantren- och stilbenderivat | |
| ES8401456A1 (es) | Procedimiento para la preparacion de 2-aminometilfenoles. | |
| DE3269505D1 (en) | Substituted 1-benzoyl-2-phenylimino-imidazolidines, their acid addition salts, process for their preparation and pharmaceutical compositions containing them | |
| DE3662048D1 (de) | Novel thyronine derivatives |